Old Web
English
Sign In
Acemap
>
authorDetail
>
Alok Shrestha
Alok Shrestha
Novartis
Myeloid leukemia
Medicine
in patient
Oncology
Internal medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CML-375: AIM4CML Trial in Progress: A Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with and without T315I Mutations
2021
Clinical Lymphoma, Myeloma & Leukemia
Moshe Y. Levy
Michael J. Mauro
Ghayas C. Issa
David Andorsky
Sarah Tomassetti
Rodrigo Maegawa
Alok Shrestha
Michael W. Deininger
Show All
Source
Cite
Save
Citations (0)
Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations
2021
Blood
David Andorsky
Sarah Tomassetti
Yehuda E. Deutsch
E. Randolph Broun
Ghayas C. Issa
Moshe Yair Levy
Michael W. Deininger
Rodrigo Maegawa
Alok Shrestha
Michael J. Mauro
Show All
Source
Cite
Save
Citations (0)
Gene Expression Signature Predicts Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML): An Exploratory Biomarker Analysis from ENESTnd
2019
Blood
Jerald P. Radich
Richard A. Larson
Hagop M. Kantarjian
Michael W. Deininger
Javier Pinilla-Ibarz
Daniel J. DeAngelo
Susan Branford
Islam Sadek
Shalini Chaturvedi
Manu Sondhi
Matthew A Wall
Kaushal Mishra
Das Purkayastha
Alok Shrestha
Vanessa Obourn
Brian S. White
Brian J. Druker
Show All
Source
Cite
Save
Citations (1)
1